Skip to main content

Table 2 Complications and outcomes of the AP patients with or without IPN

From: Reduced lymphocyte count as an early marker for predicting infected pancreatic necrosis

  Non-IPN group (n = 123) IPN group (n = 30) p Value
Severity of AP, no. (%)    <0.001
Mild 59 (48.0) 0 (0)  
Moderate 26 (21.1) 0 (0)  
Severe 38 (30.9) 4 (13.3)  
Critical 0 (0) 26 (86.7)  
Organ dysfunction, no. (%)
Respiratory 34 (27.6) 19 (63.3) <0.001
Renal 20 (16.3) 22 (73.3) <0.001
Cardiovascular 5 (4.1) 12 (40.0) <0.001
Mechanical ventilation, no. (%) 21 (17.1) 18 (60.0) <0.001
CRRT, no. (%) 20 (16.3) 19 (63.3) <0.001
Complication, no. (%)
Pancreatic pseudocyst 8 (6.5) 1 (3.3) 1.000
Invasive fungal infection 0 (0) 2 (6.7) 0.037
Intra-abdominal hemorrhage 1 (0.8) 9 (30.0) <0.001
Deep vein thrombosis 5 (4.1) 2 (6.7) 0.624
Portal thrombosis 1 (0.8) 1 (3.3) 0.355
IAH 6 (4.9) 8 (26.7) 0.001
Encephalopathy 1 (0.8) 0 (0) 1.000
Fistula 0 (0) 5 (16.7) <0.001
Hospital stay, days 10 (6, 14) 30 (18, 54) <0.001
ICU stay, days 6 (3, 9) 17 (9, 48) <0.001
Mortality rate, no. (%) 4 (3.3) 13 (43.3) <0.001
  1. IPN infected pancreatic necrosis, AP acute pancreatitis, CRRT continuous renal replacement therapy, IAH intra-abdominal hypertension, ICU intensive care unit